Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
about
Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment optionsNeonatal outcome in patients with rheumatic disease.Fetal cardiac arrhythmia detection and in utero therapyAssessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography.Atrioventricular block during fetal life.Overview of fetal arrhythmias.Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies.Finding the "PR-fect" solution: what is the best tool to measure fetal cardiac PR intervals for the detection and possible treatment of early conduction disease?Congenital heart block: evidence for a pathogenic role of maternal autoantibodiesAnti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases.Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block.Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block.Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome).Atrioventricular conduction delay in fetuses exposed to anti-SSA/Ro and anti-SSB/La antibodies: a magnetocardiography studyPregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies.Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus.Impact of in utero environment on the offspring of lupus patients.Congenital heart block: clinical features and therapeutic approaches.Spectrum of fetal echocardiographic findings in fetuses of women with clinical or serologic evidence of systemic lupus erythematosus.Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.Atrioventricular conduction delay in the second trimester measured by fetal magnetocardiography.Prenatal evaluation and management of fetuses exposed to Anti-SSA/Ro antibodies.Cutaneous neonatal lupus: a case report and review of the literature.Late development of complete atrioventricular block may be immune mediated and congenital in origin.Congenital heart block: current thoughts on management, morphologic spectrum, and role of intervention.The clinical spectrum of autoimmune congenital heart block.Autoimmune congenital heart block: complex and unusual situations.Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years--a retrospective cohort study.Ro/SSA autoantibody-positive pregnancy: reactions to serial fetal Doppler echocardiographic surveillance.Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.A population-based investigation of the autoantibody profile in mothers of children with atrioventricular block.Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus.Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.Anti-SSA antibodies are present in immunoglobulin preparations.Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy.Long-term growth of children with autoantibody-mediated congenital heart block.Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.
P2860
Q24804359-76B4D88C-FDA8-4A60-A6E5-4AB6D6630F5AQ33363243-720CB21A-04E8-4FDA-9EEE-CE7B3678DD5DQ34369640-C75620DC-5027-45AB-8FF7-6A2AAA96738DQ35772856-F54B575B-CCCC-4C57-BD9A-338D59B28469Q35783831-9C724141-2234-4BD6-BB53-7B1E76EE9E0BQ35889869-1FBAC2A4-0A95-40C7-9472-86580CD301CFQ36057203-B3ECAF55-3AD0-4CE5-8645-28B69B75D793Q36095085-1754C432-2509-4DBD-96B3-9E816590973CQ36245765-ED31F316-6C33-4A71-B707-B4F01E4634F1Q36272782-3ADD79E7-6209-4723-A97C-D85118BA0A98Q36283419-85E2F75C-F114-46B8-8375-81636EC3A0CAQ36402505-E1684B3C-9357-4D4E-AC17-09B017AEC2CEQ36458150-5B51D0DE-1E1E-4865-A185-A5D8895C50B8Q36516100-362A52F1-BED3-4CC0-917E-B2995AECA78BQ36570988-DC6BE494-50F7-40EA-8200-26101E821A01Q36596375-D21EB52F-600E-40F1-97D8-D44B3CCDC941Q36672541-6E838EB2-2C36-41E1-B7FE-DDBC42810AC9Q36677036-D2D7FFB2-E412-44D7-A5F6-8DA5D254786DQ36915673-6A588F3B-48CC-4745-AAE3-C28CE5C5526EQ37334176-36E2DC6C-5750-4721-98D0-8B533057918FQ37393128-EC330CB5-F223-4F13-AE2A-274EC4C08F0FQ37704953-68779A68-27C8-484E-9069-DE0630C3F439Q38012039-4021FAFC-CAF4-41DC-8C59-9E56BD514B1AQ38123556-81B0AAA7-68FA-4E33-9299-63C1C6DCB5B9Q38155938-D82A210F-C5D5-4438-8848-F07F726903F5Q38253376-E32C8B29-5BD7-4646-9B1E-48C389F7E464Q38387739-7640FDC4-C45F-4392-86FB-747F85F6CE08Q38695221-EC456ACF-55C8-4347-ADD4-614B53F40AF9Q40494645-34252CA1-07DC-4BC0-B3C3-33B1DF3E006FQ40524514-01339300-F155-4AEE-AA34-690D9E591282Q40795197-339A392E-DCF0-4DCB-B319-25E6DECC7DF6Q43421348-11A25C18-6ECA-47B7-828B-A64AF97E2CBEQ44355666-B7AB7334-BDF4-47D4-AE61-A79F8F6255E1Q45804571-A92CB92A-0D9F-4E32-81B6-FAC252A444D8Q47731190-625CB1D3-DA57-4E02-A077-9EAC653E9BB4Q48253282-942CBDBD-4C26-4C26-807B-F8FF03FBD3DBQ48262439-4D501B58-FFF9-4927-83F6-DDEF8634D5F5Q50862132-C25E14B0-5441-4E06-9C94-FE4758485CECQ51557775-58213C78-1E71-4A7A-AE1C-761C2DA9649BQ51686879-36FE8722-C7CA-41A4-ACAB-E729AEB81407
P2860
Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Signs of first-degree heart bl ...... anti-SSA/Ro 52-kd antibodies.
@en
Signs of first-degree heart bl ...... anti-SSA/Ro 52-kd antibodies.
@nl
type
label
Signs of first-degree heart bl ...... anti-SSA/Ro 52-kd antibodies.
@en
Signs of first-degree heart bl ...... anti-SSA/Ro 52-kd antibodies.
@nl
prefLabel
Signs of first-degree heart bl ...... anti-SSA/Ro 52-kd antibodies.
@en
Signs of first-degree heart bl ...... anti-SSA/Ro 52-kd antibodies.
@nl
P2093
P356
P1476
Signs of first-degree heart bl ...... anti-SSA/Ro 52-kd antibodies.
@en
P2093
Katarina Bremme
Lilly-Ann Jacobsson
Stina Salomonsson
Sven-Erik Sonesson
P304
P356
10.1002/ART.20126
P577
2004-04-01T00:00:00Z